Anatara Lifesciences provided an update on progress of clinical trials in psychological functioning and irritable bowel syndrome, diarrhoea subtype (IBS-D). Continuing recruitment for two human clinical trials with ethics approval: GaRP in Irritable Bowel Syndrome - diarrhoea subtype (IBS-D); Trial sites: Paratus Clinical Research (Brisbane, Canberra, Central Coast NSW, Western Sydney); CSIRO Nutrition and Health Research Clinic (Adelaide); Anticipated results: Interim August 2022; Final January 2023; 3FDC in psychological functioning (anxiety, depression, stress); Trial site: CSIRO Nutrition and Health Research Clinic (Adelaide); Anticipated results: Final late 2022; Exploring opportunities to bring forward anticipated dates for results; Further expansion of eligibility criteria for both trials; Anticipated addition of Melbourne site for IBS-D trial in May 2022.